Automated Breast Ultrasound Systems Market Set to Register a CAGR of 14.20% and Reach USD 10.11 Billion by 2031 – Growth Plus Reports

<!– Name:DistributionId Value:8800438 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1222559 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:cbf56c15-31f1-4902-a860-6965417e842c –>

Newark, New Castle, USA, April 03, 2023 (GLOBE NEWSWIRE) — According to the latest Growth Plus Reports assessment, the automated breast ultrasound systems market is estimated to reach US$ 10.11 billion by 2031, with a CAGR of 14.20%. The report analyzes vital growth strategies, factors, prospects, competition, industry trends, market dynamics, data and forecasts, and ideal investment regions.

Key Takeaways:

• The increased prevalence of breast cancer will drive the market’s revenue growth.

• North America will register the fastest-revenue growth in the automated breast ultrasound systems market.

• The need for advanced imaging will fuel the growth of the market. 

Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/automated-breast-ultrasound-systems-market/8482

Automated Breast Ultrasound Systems Market Scope

Market Drivers
The advances in automated breast ultrasound (ABUS) are the major factors driving the revenue growth of the global automated breast ultrasound systems market. Furthermore, the increasing demand for more advanced cancer imaging, the rapidly increasing number of breast cancer patients, and the launch of novel products contribute to the market’s revenue growth rate. 

Market Segmentation
Growth Plus Reports has analyzed the global automated breast ultrasound systems market from four perspectives: Product, End User, and Region.

Product Segmentation: On the basis of product, the automated breast ultrasound systems market is segmented into automated breast ultrasound systems (ABUS) and breast volume scanners (ABVS). The automated breast ultrasound systems (ABUS) segment accounts for the largest revenue share because of technological advancements and user-friendly device features.

End-User Segmentation: Based on the end-user, the global automated breast ultrasound systems market is segmented into hospitals, diagnostics imaging laboratories, and clinics. The hospital segment dominates the market because of the increased prevalence of breast cancer, the introduction of technologically advanced products, and growing awareness about the condition and its treatment.
  
Regional Growth Dynamics
Based on the region, the global automated breast ultrasound systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the automated breast ultrasound systems market with the largest revenue share. The dominance of North America is attributed to the increasing prevalence of cancer, the presence of key players, advanced healthcare infrastructure, and favorable reimbursement policies.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/automated-breast-ultrasound-systems-market/8482

Competitive Landscape
The prominent players in the global automated breast ultrasound systems market are:

• General Electric Company
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Telemed Medical Systems
• Canon Medical Systems Corporation
• Fukuda Denshi
• Nova Medical Imaging Technology Co. Ltd
• Hologic, Inc.
• SuperSonic Imagine
• QView Medical Inc.

The automated breast ultrasound systems market is extremely competitive, with several players involved. Market giants use mergers, collaborations, and acquisitions to increase their market share and launch new drugs and products.

Recent developments:

• CAD, Inc., iCAD, Inc., a global medical technology company that provides advanced cancer detection and therapy solutions, and Ferrum Health, a pioneer in healthcare enterprise AI solutions, have agreed to make iCAD’s breast AI solutions available on Ferrum Health’s platform beginning in November 2022.

• Siemens Healthineers and HeartVista partnered in November 2022 to completely integrate HeartVista’s artificial intelligence algorithms for chest imaging into Siemens’ MRI equipment. The two firms collaborated to develop an automated clinical imaging procedure that uses MRI sequences (techniques).

• Accuray Incorporated announced in October 2022 that, in collaboration with C-RAD AB, it would provide a crucial new alternative for enhancing the care of women with breast cancer. In December 2021, Health Canada will approve its first domestically made 3D printed implant Specific 3D mandibular plate.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET – ANALYSIS & FORECAST, BY PRODUCT
   1. Automated Breast Ultrasound System 
   2. Automated Breast Volume Scanner
6. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET – ANALYSIS & FORECAST, BY END USER
   1. Hospitals
   2. Diagnostics Imaging Laboratories
   3. Others

AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8482

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse related reports:

Leadless Cardiac Pacemaker Market by Type (Micra Transcatheter Pacing System, Aveir VR Leadless Pacemaker), by Condition (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block) – Global Outlook & Forecast 2022-2030

Digital Experience Platform Market by Component (Services and Platform), by Deployment Type (Cloud-Based and On-Premises), by Application (Business to Business and Business to Customer), and by End User (IT & Telecom, Healthcare, Media and Entertainment, Education, BFSI, and Retail) – Global Outlook & Forecast 2022-2030

Biliary Stents Market by Type (Metal Stents and Polymer Stents), by Application (Gallstones, Bilio-Pancreatic Leakages, Malignant Obstruction, and Benign Biliary Structures) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) – Global Outlook & Forecast 2022-2030

Dehydration Monitoring Systems Market by Product (Mobile Devices, Wearable Devices), by Application (Disease Diagnosis, Drug Abuse Detection, Athletic Performance Optimization) – Global Outlook & Forecast 2022-2030

Hearing Aids Devices Market by Product (Hearing Devices and Hearing Implants), by Patient Type (Adults and Pediatrics), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Outlook & Forecast 2022-2030

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.